Hematologic Oncology Update, Issue 3, 2016 (Video Program) - Video 1


Obinutuzumab: Mechanism of action, activity and management of treatment-associated infusion reactions
2:53 minutes.

Non-Hodgkin lymphoma (NHL), Hodgkin lymphoma and chronic lymphocytic leukemia (CLL)

Acute and chronic leukemias and myeloproliferative neoplasms

Multiple myeloma (MM)